MAEA and breast cancer: Therefore, we evaluated the expression of the established EMP markers in breast cancer—SNAIL and KRT14—together with other key proteins involved in EMT, such as β-catenin, YAP and its downstream effector CYR61, in shERK3 and shWT cells.